Reduced CD160 Expression Contributes to Impaired NK Cell Function and Poor Clinical Outcomes in Patients With HCC

Cancer Research - United States
doi 10.1158/0008-5472.can-18-1049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search